Immunotherapies, such as immune checkpoint inhibitors (e.g., anti‐PD‐1/PD‐L1, anti‐CTLA‐4), enhance the immune system's ability to recognize and destroy cancer cells. This evidence concerns the gene CD274 and cancer.